BIOS ACTUATE CO-INVEST III, LP

Profile

Company Names

BIOS ACTUATE CO-INVEST III, LP

Addresses

1751 RIVER RUN, SUITE 400, FORT WORTH, TX 76107

Phone Numbers

817-345-6829

 

Entity Type:

LIMITED PARTNERSHIP

Industry:

VENTURE CAPITAL FUND

Year Incorporated:

2022

State Incorporated:

DELAWARE

Total Amount Raised:

$3,200,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2022-09-30 
$3,200,000.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
- 
 
BIOS ADVISORS GP, LLC 
DIRECTOR
BIOS ACTUATE CO-INVEST III, LP   |  BIOS I-LUMEN CO-INVEST I, LP
- 
 
BIOS CAPITAL MANAGEMENT, LP 
PROMOTER
BIOS ACTUATE CO-INVEST III, LP   |  BIOS CLINICAL OPPORTUNITY FUND, LP   |  BIOS 2024 CO-INVEST, LP   |  BIOS ONL CO-INVEST II, LP   |  BIOS 2026 CO-INVEST, LP
- 
 
BIOS EQUITY PARTNERS III, LP 
DIRECTOR
BIOS ACTUATE CO-INVEST III, LP
- 
 
CAVU ADVISORS, LLC 
DIRECTOR
BIOS ACTUATE CO-INVEST III, LP
- 
 
CAVU MANAGEMENT, LP 
PROMOTER
BIOS ACTUATE CO-INVEST III, LP
AARON 
G.L. 
FLETCHER 
EXECUTIVE OFFICER
LUNG THERAPEUTICS, INC.   |  BIOS SPECIAL OPPORTUNITY FUND, LP   |  BIOS ACTUATE CO-INVEST III, LP   |  BIOS CLINICAL OPPORTUNITY FUND, LP   |  BIOS 2024 CO-INVEST, LP   |  BIOS ONL CO-INVEST II, LP   |  ACTUATE THERAPEUTICS, INC.
LESLIE 
WAYNE 
KREIS JR. 
EXECUTIVE OFFICER
ACTUATE THERAPEUTICS, INC.   |  BIOS ACTUATE CO-INVEST III, LP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-12-06
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#